The Effect of Postoperative Antithrombin Supplementation on the Inflammatory and Coagulation Status of a Surgically Treated Patient With a Malignant Tumor in the Small Pelvis—Case Series

ABSTRACT Introduction Antithrombin has the function of a natural anticoagulant. It is the main component of the inhibitory anticoagulant system, which, under physiological conditions, opposes the procoagulant mechanisms of hemostasis, preventing the occurrence of a hypercoagulable state, the develop...

Full description

Saved in:
Bibliographic Details
Main Authors: Ranko Lazović, Ognjenka Šarenac
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Cancer Reports
Subjects:
Online Access:https://doi.org/10.1002/cnr2.70260
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849433506123350016
author Ranko Lazović
Ognjenka Šarenac
author_facet Ranko Lazović
Ognjenka Šarenac
author_sort Ranko Lazović
collection DOAJ
description ABSTRACT Introduction Antithrombin has the function of a natural anticoagulant. It is the main component of the inhibitory anticoagulant system, which, under physiological conditions, opposes the procoagulant mechanisms of hemostasis, preventing the occurrence of a hypercoagulable state, the development of thrombosis, and thromboembolic complications. Antithrombin deficiency, acquired or congenital, leads to the development of a hypercoagulable state and thromboembolic complications. Antithrombin also has a significant anti‐inflammatory, antimicrobial, and antitumor effect. Patients with malignant diseases are often in a hypercoagulable and proinflammatory state due to the nature of the disease itself and the fact that they undergo extensive surgical procedures and chemotherapy as therapeutic modalities. Therapeutic supplementation with antithrombin products could establish normal coagulability and reduce or suppress the inflammatory response. However, previous randomized studies have not shown a long‐term benefit of this approach. Case In our female patients who underwent multiple organ resections, with advanced colorectal cancer and acute pancreatitis treated surgically, with a pronounced inflammatory and hypercoagulable response on the first postoperative day, antithrombin supplementation in the first four postoperative days contributed to the establishment of normal coagulability confirmed by the ROTEM analysis while suppressing the inflammatory response followed by inflammatory laboratory parameters. Conclusion Compensating for the antithrombin deficit in the first four postoperative days may benefit the specified patient group, with careful monitoring of hemostatic and inflammatory parameters.
format Article
id doaj-art-7369cdcee69f4df0bc339f8a03ac84fb
institution Kabale University
issn 2573-8348
language English
publishDate 2025-06-01
publisher Wiley
record_format Article
series Cancer Reports
spelling doaj-art-7369cdcee69f4df0bc339f8a03ac84fb2025-08-20T03:27:01ZengWileyCancer Reports2573-83482025-06-0186n/an/a10.1002/cnr2.70260The Effect of Postoperative Antithrombin Supplementation on the Inflammatory and Coagulation Status of a Surgically Treated Patient With a Malignant Tumor in the Small Pelvis—Case SeriesRanko Lazović0Ognjenka Šarenac1Clinic for Surgery, Clinical Center of Montenegro University of Montenegro Faculty of Medicine Podgorica MontenegroClinic for Anesthesia, Resuscitation and Pain Management, Clinical Center of Montenegro University of Montenegro Faculty of Medicine Podgorica MontenegroABSTRACT Introduction Antithrombin has the function of a natural anticoagulant. It is the main component of the inhibitory anticoagulant system, which, under physiological conditions, opposes the procoagulant mechanisms of hemostasis, preventing the occurrence of a hypercoagulable state, the development of thrombosis, and thromboembolic complications. Antithrombin deficiency, acquired or congenital, leads to the development of a hypercoagulable state and thromboembolic complications. Antithrombin also has a significant anti‐inflammatory, antimicrobial, and antitumor effect. Patients with malignant diseases are often in a hypercoagulable and proinflammatory state due to the nature of the disease itself and the fact that they undergo extensive surgical procedures and chemotherapy as therapeutic modalities. Therapeutic supplementation with antithrombin products could establish normal coagulability and reduce or suppress the inflammatory response. However, previous randomized studies have not shown a long‐term benefit of this approach. Case In our female patients who underwent multiple organ resections, with advanced colorectal cancer and acute pancreatitis treated surgically, with a pronounced inflammatory and hypercoagulable response on the first postoperative day, antithrombin supplementation in the first four postoperative days contributed to the establishment of normal coagulability confirmed by the ROTEM analysis while suppressing the inflammatory response followed by inflammatory laboratory parameters. Conclusion Compensating for the antithrombin deficit in the first four postoperative days may benefit the specified patient group, with careful monitoring of hemostatic and inflammatory parameters.https://doi.org/10.1002/cnr2.70260antithrombincolorectal neoplasmshemostasisinflammationpancreatitis
spellingShingle Ranko Lazović
Ognjenka Šarenac
The Effect of Postoperative Antithrombin Supplementation on the Inflammatory and Coagulation Status of a Surgically Treated Patient With a Malignant Tumor in the Small Pelvis—Case Series
Cancer Reports
antithrombin
colorectal neoplasms
hemostasis
inflammation
pancreatitis
title The Effect of Postoperative Antithrombin Supplementation on the Inflammatory and Coagulation Status of a Surgically Treated Patient With a Malignant Tumor in the Small Pelvis—Case Series
title_full The Effect of Postoperative Antithrombin Supplementation on the Inflammatory and Coagulation Status of a Surgically Treated Patient With a Malignant Tumor in the Small Pelvis—Case Series
title_fullStr The Effect of Postoperative Antithrombin Supplementation on the Inflammatory and Coagulation Status of a Surgically Treated Patient With a Malignant Tumor in the Small Pelvis—Case Series
title_full_unstemmed The Effect of Postoperative Antithrombin Supplementation on the Inflammatory and Coagulation Status of a Surgically Treated Patient With a Malignant Tumor in the Small Pelvis—Case Series
title_short The Effect of Postoperative Antithrombin Supplementation on the Inflammatory and Coagulation Status of a Surgically Treated Patient With a Malignant Tumor in the Small Pelvis—Case Series
title_sort effect of postoperative antithrombin supplementation on the inflammatory and coagulation status of a surgically treated patient with a malignant tumor in the small pelvis case series
topic antithrombin
colorectal neoplasms
hemostasis
inflammation
pancreatitis
url https://doi.org/10.1002/cnr2.70260
work_keys_str_mv AT rankolazovic theeffectofpostoperativeantithrombinsupplementationontheinflammatoryandcoagulationstatusofasurgicallytreatedpatientwithamalignanttumorinthesmallpelviscaseseries
AT ognjenkasarenac theeffectofpostoperativeantithrombinsupplementationontheinflammatoryandcoagulationstatusofasurgicallytreatedpatientwithamalignanttumorinthesmallpelviscaseseries
AT rankolazovic effectofpostoperativeantithrombinsupplementationontheinflammatoryandcoagulationstatusofasurgicallytreatedpatientwithamalignanttumorinthesmallpelviscaseseries
AT ognjenkasarenac effectofpostoperativeantithrombinsupplementationontheinflammatoryandcoagulationstatusofasurgicallytreatedpatientwithamalignanttumorinthesmallpelviscaseseries